Welcome
Support Centre
09 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised trial comparing the efficacy and costs of endoscopy with Helicobacter pylori testing versus non-invasive Helicobacter pylori testing alone in the management of dyspepsia
ISRCTN ISRCTN91662361
ClinicalTrials.gov identifier
Public title Randomised trial comparing the efficacy and costs of endoscopy with Helicobacter pylori testing versus non-invasive Helicobacter pylori testing alone in the management of dyspepsia
Scientific title
Acronym N/A
Serial number at source HTA 94/41/17
Study hypothesis Dyspepsia is a common problem in the U.K. and accounts for 10% of GP attendance and 30% of hospital GI clinic referrals. Patients with persisting dyspepsia are investigated by upper GI endoscopy in order to diagnose the underlying cause and determine the most appropriate management. The demand for diagnostic endoscopy continues to increase and currently costs the NHS more than 100 million per year. The procedure also causes the patient significant discomfort and inconvenience.
Studies in our own unit and other centres suggests that non-invasive Helicobacter pylori testing might replace endoscopy in determining the management of a substantial proportion of patients with simple dyspepsia. In order to asses this we propose a randomised controlled trial comparing endoscopy versus non-invasive H.pylori testing in patients with dyspepsia who are less than 55 years and have no sinister symptoms. The study will also allow identification of the patients who will benefit most from the non-endoscopic management. The ability to replace endoscopy by non-invasive test should result in major savings to the health budget and save the patient the discomfort of invasive procedure. It will also allow most dyspeptic patients to be managed definitively in primary care and without the need to attend hospital clinics or endoscopy units.
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Digestive system diseases: Peptic ulcer disease
Participants - inclusion criteria Patients with dyspepsia who are less than 55 years old with no sinister symptoms
Participants - exclusion criteria Not provided at time of registration.
Anticipated start date 01/08/1997
Anticipated end date 31/08/2001
Status of trial Completed
Patient information material
Target number of participants 708
Interventions 1. Endoscopy
2. Non-invasive H. pylori testing
Primary outcome measure(s) Glasgow dyspepsia severity score at one year.
Secondary outcome measure(s) Use of medical resources, patient oriented outcomes, and safety were also assessed.
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11976239
Contact name Prof  Kenneth  McColl
  Address University Dept of Medicine and Therapeutics
University of Glasgow
44 Church Street
  City/town Glasgow
  Zip/Postcode G11 6NT
  Country United Kingdom
  Tel +44 (0)141 211 2513
  Fax +44 (0)141 339 2800
  Email K.E.L.McColl@clinmed.gla.ac.uk
Sponsor Department of Health (UK)
  Address Quarry House
Quarry Hill
  City/town Leeds
  Zip/Postcode LS2 7UE
  Country United Kingdom
  Email Sheila.Greener@doh.gsi.gov.uk
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 25/04/2003
Last edited 25/01/2008
Date ISRCTN assigned 25/04/2003
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central